$BASI Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Inotiv, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Inotiv, Inc.. Get notifications about new insider transactions in Inotiv, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 11 2021 | BASI | Inotiv, Inc. | Taylor Beth | VP- Finance & CFO | Grant | A | 0.00 | 880 | 0 | 35,175 | 34.3 K to 35.2 K (+2.57 %) |
May 11 2021 | BASI | Inotiv, Inc. | Leasure Robert Jr. | President and CEO | Grant | A | 0.00 | 3,667 | 0 | 230,216 | 226.5 K to 230.2 K (+1.62 %) |
May 11 2021 | BASI | Inotiv, Inc. | Sagartz John E | Chief Strategy Offi ... | Grant | A | 0.00 | 880 | 0 | 644,765 | 643.9 K to 644.8 K (+0.14 %) |
May 11 2021 | BASI | Inotiv, Inc. | Pitchford William D | Chief HR Officer | Grant | A | 0.00 | 880 | 0 | 40,421 | 39.5 K to 40.4 K (+2.23 %) |
May 11 2021 | BASI | Inotiv, Inc. | Flynn Joseph Earl | Chief Commercial Of ... | Grant | A | 0.00 | 880 | 0 | 128,394 | 127.5 K to 128.4 K (+0.69 %) |
May 11 2021 | BASI | Inotiv, Inc. | Beattie John Gregory | Chief Operating Off ... | Grant | A | 0.00 | 440 | 0 | 25,440 | 25 K to 25.4 K (+1.76 %) |
Mar 05 2021 | BASI | BIOANALYTICAL SYST ... | Taylor Beth | VP- Finance & CFO | Buy | P | 17.70 | 5,000 | 88,500 | 34,295 | 29.3 K to 34.3 K (+17.07 %) |
Mar 05 2021 | BASI | BIOANALYTICAL SYST ... | Taylor Beth | VP- Finance & CFO | Buy | P | 17.70 | 5,000 | 88,500 | 34,295 | 29.3 K to 34.3 K (+17.07 %) |
Feb 25 2021 | BASI | BIOANALYTICAL SYST ... | Beattie John Gregory | Chief Operating Off ... | Buy | P | 14.00 | 8,288 | 116,032 | 23,288 | 15 K to 23.3 K (+55.25 %) |
Dec 30 2020 | BASI | BIOANALYTICAL SYST ... | Leasure Robert Jr. | President and CEO | Grant | A | 0.00 | 40,000 | 0 | 226,549 | 186.5 K to 226.5 K (+21.44 %) |
Dec 04 2020 | BASI | BIOANALYTICAL SYST ... | Downing Philip A | Sr. VP, Preclinical ... | Grant | A | 0.00 | 7,964 | 0 | 42,165 | 34.2 K to 42.2 K (+23.29 %) |
Dec 04 2020 | BASI | BIOANALYTICAL SYST ... | Taylor Beth | VP- Finance & CFO | Grant | A | 0.00 | 5,995 | 0 | 29,295 | 23.3 K to 29.3 K (+25.73 %) |
Dec 04 2020 | BASI | BIOANALYTICAL SYST ... | Pitchford William D | Chief HR Officer | Grant | A | 0.00 | 7,541 | 0 | 39,541 | 32 K to 39.5 K (+23.57 %) |
Dec 04 2020 | BASI | BIOANALYTICAL SYST ... | Baim Michael | VP Bioanalytical Se ... | Grant | A | 0.00 | 6,938 | 0 | 14,656 | 7.7 K to 14.7 K (+89.89 %) |
Dec 04 2020 | BASI | BIOANALYTICAL SYST ... | Sagartz John E | Chief Strategy Offi ... | Grant | A | 0.00 | 9,653 | 0 | 643,885 | 634.2 K to 643.9 K (+1.52 %) |
Aug 20 2020 | BASI | BIOANALYTICAL SYST ... | Sagartz John E | Chief Strategy Offi ... | Buy | P | 4.75 | 3,733 | 17,732 | 634,232 | 630.5 K to 634.2 K (+0.59 %) |
Aug 19 2020 | BASI | BIOANALYTICAL SYST ... | Neff R Matthew | Director | Buy | P | 4.75 | 5,000 | 23,750 | 60,350 | 55.4 K to 60.4 K (+9.03 %) |
Jun 16 2020 | BASI | BIOANALYTICAL SYST ... | Leasure Robert Jr. | President and CEO | Buy | P | 5.20 | 2,884 | 14,997 | 186,549 | 183.7 K to 186.5 K (+1.57 %) |
Jun 11 2020 | BASI | BIOANALYTICAL SYST ... | Taylor Beth | VP- Finance & CFO | Grant | A | 0.00 | 10,000 | 0 | 23,300 | 13.3 K to 23.3 K (+75.19 %) |
May 22 2020 | BASI | BIOANALYTICAL SYST ... | Pitchford William D | Chief HR Officer | Buy | P | 4.47 | 10,000 | 44,700 | 32,000 | 22 K to 32 K (+45.45 %) |
May 21 2020 | BASI | BIOANALYTICAL SYST ... | Taylor Beth | VP- Finance & CFO | Buy | P | 4.52 | 3,300 | 14,916 | 13,300 | 10 K to 13.3 K (+33.00 %) |
May 21 2020 | BASI | BIOANALYTICAL SYST ... | Taylor Beth | VP- Finance & CFO | Buy | P | 4.42 | 4,933 | 21,804 | 10,000 | 5.1 K to 10 K (+97.36 %) |
May 21 2020 | BASI | BIOANALYTICAL SYST ... | Taylor Beth | VP- Finance & CFO | Buy | P | 4.38 | 5,067 | 22,193 | 5,067 | 0 to 5.1 K |
Apr 03 2020 | BASI | BIOANALYTICAL SYST ... | Davis Gregory Cole | Director | Grant | A | 0.00 | 10,000 | 0 | 30,000 | 20 K to 30 K (+50.00 %) |
Apr 03 2020 | BASI | BIOANALYTICAL SYST ... | Johnson Richard Allen | Director | Grant | A | 0.00 | 10,000 | 0 | 40,000 | 30 K to 40 K (+33.33 %) |
Apr 03 2020 | BASI | BIOANALYTICAL SYST ... | Neff R Matthew | Director | Grant | A | 0.00 | 10,000 | 0 | 55,350 | 45.4 K to 55.4 K (+22.05 %) |
Mar 17 2020 | BASI | BIOANALYTICAL SYST ... | Leasure Robert Jr. | President and CEO | Buy | P | 3.49 | 5,700 | 19,893 | 183,665 | 178 K to 183.7 K (+3.20 %) |
Feb 21 2020 | BASI | BIOANALYTICAL SYST ... | Neff R Matthew | Director | Buy | P | 4.60 | 9,458 | 43,507 | 30,000 | 20.5 K to 30 K (+46.04 %) |
Feb 20 2020 | BASI | BIOANALYTICAL SYST ... | Johnson Richard Allen | Director | Buy | P | 4.63 | 20,000 | 92,600 | 30,000 | 10 K to 30 K (+200.00 %) |
Jan 29 2020 | BASI | BIOANALYTICAL SYST ... | Leasure Robert Jr. | President and CEO | Option Exercise | A | 5.03 | 45,000 | 226,350 | 45,000 | |
Jan 29 2020 | BASI | BIOANALYTICAL SYST ... | Leasure Robert Jr. | President and CEO | Grant | A | 0.00 | 13,000 | 0 | 177,965 | 165 K to 178 K (+7.88 %) |
Dec 04 2019 | BASI | BIOANALYTICAL SYST ... | Sagartz John E | Director | Grant | A | 0.00 | 8,974 | 0 | 630,499 | 621.5 K to 630.5 K (+1.44 %) |
Dec 04 2019 | BASI | BIOANALYTICAL SYST ... | Blumhoff Jill | VP, Finance & CFO | Grant | A | 0.00 | 7,000 | 0 | 8,811 | 1.8 K to 8.8 K (+386.53 %) |
Dec 04 2019 | BASI | BIOANALYTICAL SYST ... | Oakley Daniel Thomas | Chief Operating Off ... | Grant | A | 0.00 | 8,974 | 0 | 57,520 | 48.5 K to 57.5 K (+18.49 %) |
Dec 04 2019 | BASI | BIOANALYTICAL SYST ... | Flynn Joseph Earl | Chief Commercial Of ... | Grant | A | 0.00 | 2,564 | 0 | 127,514 | 125 K to 127.5 K (+2.05 %) |
Dec 04 2019 | BASI | BIOANALYTICAL SYST ... | Downing Philip A | Sr. VP, Preclinical ... | Grant | A | 0.00 | 8,436 | 0 | 34,201 | 25.8 K to 34.2 K (+32.74 %) |
Dec 04 2019 | BASI | BIOANALYTICAL SYST ... | Baim Michael | VP Bioanalytical Se ... | Grant | A | 0.00 | 7,718 | 0 | 22,718 | 15 K to 22.7 K (+51.45 %) |
Sep 16 2019 | BASI | BIOANALYTICAL SYST ... | Leasure Robert Jr. | President and CEO | Buy | P | 3.72 | 26,846 | 99,867 | 164,965 | 138.1 K to 165 K (+19.44 %) |
Sep 16 2019 | BASI | BIOANALYTICAL SYST ... | Oakley Daniel Thomas | Chief Operating Off ... | Buy | P | 3.65 | 1,000 | 3,650 | 48,546 | 47.5 K to 48.5 K (+2.10 %) |
Sep 16 2019 | BASI | BIOANALYTICAL SYST ... | Pitchford William D | Chief HR Officer | Buy | P | 3.70 | 12,000 | 44,400 | 22,000 | 10 K to 22 K (+120.00 %) |
Sep 11 2019 | BASI | BIOANALYTICAL SYST ... | Perrow Wendy | Director | Buy | P | 3.62 | 10,000 | 36,200 | 10,000 | 0 to 10 K |
Sep 06 2019 | BASI | BIOANALYTICAL SYST ... | Pitchford William D | Chief HR Officer | Grant | A | 0.00 | 10,000 | 0 | 10,000 | 0 to 10 K |
Sep 06 2019 | BASI | BIOANALYTICAL SYST ... | Oakley Daniel Thomas | Chief Operating Off ... | Buy | P | 3.35 | 2,000 | 6,700 | 47,546 | 45.5 K to 47.5 K (+4.39 %) |
Sep 06 2019 | BASI | BIOANALYTICAL SYST ... | Oakley Daniel Thomas | Chief Operating Off ... | Buy | P | 3.45 | 10,500 | 36,225 | 45,546 | 35 K to 45.5 K (+29.96 %) |
Sep 05 2019 | BASI | BIOANALYTICAL SYST ... | Leasure Robert Jr. | President and CEO | Buy | P | 3.15 | 11,500 | 36,225 | 138,119 | 126.6 K to 138.1 K (+9.08 %) |
Sep 03 2019 | BASI | BIOANALYTICAL SYST ... | Oakley Daniel Thomas | Chief Operating Off ... | Buy | P | 2.69 | 5,000 | 13,450 | 36,046 | 31 K to 36 K (+16.11 %) |
Aug 26 2019 | BASI | BIOANALYTICAL SYST ... | Oakley Daniel Thomas | Chief Operating Off ... | Buy | P | 2.77 | 2,594 | 7,185 | 31,046 | 28.5 K to 31 K (+9.12 %) |
Aug 20 2019 | BASI | BIOANALYTICAL SYST ... | Leasure Robert Jr. | President and CEO | Buy | P | 2.19 | 16,000 | 35,040 | 126,619 | 110.6 K to 126.6 K (+14.46 %) |
Jun 14 2019 | BASI | BIOANALYTICAL SYST ... | Neff R Matthew | Director | Buy | P | 1.98 | 1,410 | 2,792 | 22,125 | 20.7 K to 22.1 K (+6.81 %) |
Jun 14 2019 | BASI | BIOANALYTICAL SYST ... | Leasure Robert Jr. | President and CEO | Buy | P | 1.97 | 5,000 | 9,850 | 110,619 | 105.6 K to 110.6 K (+4.73 %) |
Jun 14 2019 | BASI | BIOANALYTICAL SYST ... | Leasure Robert Jr. | President and CEO | Buy | P | 1.94 | 4 | 8 | 105,619 | 105.6 K to 105.6 K (0.00 %) |
Jun 14 2019 | BASI | BIOANALYTICAL SYST ... | Oakley Daniel Thomas | Chief Operating Off ... | Buy | P | 1.99 | 7,500 | 14,925 | 28,452 | 21 K to 28.5 K (+35.80 %) |
Jun 13 2019 | BASI | BIOANALYTICAL SYST ... | Blumhoff Jill | VP, Finance & CFO | Buy | P | 1.98 | 500 | 990 | 1,811 | 1.3 K to 1.8 K (+38.14 %) |
Jun 11 2019 | BASI | BIOANALYTICAL SYST ... | Downing Philip A | Sr. VP, Preclinical ... | Buy | P | 1.96 | 5,000 | 9,800 | 25,765 | 20.8 K to 25.8 K (+24.08 %) |
Jun 10 2019 | BASI | BIOANALYTICAL SYST ... | Leasure Robert Jr. | President and CEO | Buy | P | 1.96 | 5,000 | 9,800 | 105,615 | 100.6 K to 105.6 K (+4.97 %) |
Jun 10 2019 | BASI | BIOANALYTICAL SYST ... | Leasure Robert Jr. | President and CEO | Buy | P | 1.95 | 1,000 | 1,950 | 100,615 | 99.6 K to 100.6 K (+1.00 %) |
Apr 24 2019 | BASI | BIOANALYTICAL SYST ... | Flynn Joseph Earl | Chief Commercial Of ... | Buy | J | 0.00 | 124,950 | 0 | 124,950 | 0 to 125 K |
Apr 24 2019 | BASI | BIOANALYTICAL SYST ... | SW Chrysalis, LLC | 10% Owner | Buy | J | 0.00 | 1,500,000 | 0 | 0 | -1,500,000 to 0 (-100.00 %) |
Apr 24 2019 | BASI | BIOANALYTICAL SYST ... | Sagartz Kimberly L | 10% Owner | Buy | J | 0.00 | 632,475 | 0 | 632,475 | 0 to 632.5 K |
Mar 19 2019 | BASI | BIOANALYTICAL SYST ... | Oakley Daniel Thomas | Chief Operating Off ... | Buy | P | 1.90 | 1 | 2 | 20,952 | 21 K to 21 K (0.00 %) |
Mar 14 2019 | BASI | BIOANALYTICAL SYST ... | Sagartz John E | Director | Buy | P | 1.94 | 1,400 | 2,716 | 3,900 | 2.5 K to 3.9 K (+56.00 %) |
Mar 14 2019 | BASI | BIOANALYTICAL SYST ... | Leasure Robert Jr. | President and CEO | Buy | P | 1.94 | 6,000 | 11,640 | 99,615 | 93.6 K to 99.6 K (+6.41 %) |
Mar 11 2019 | BASI | BIOANALYTICAL SYST ... | Leasure Robert Jr. | President and CEO | Buy | P | 1.77 | 4,000 | 7,080 | 93,615 | 89.6 K to 93.6 K (+4.46 %) |
Mar 11 2019 | BASI | BIOANALYTICAL SYST ... | Neff R Matthew | Director | Buy | P | 1.75 | 5,715 | 10,001 | 20,715 | 15 K to 20.7 K (+38.10 %) |
Mar 07 2019 | BASI | BIOANALYTICAL SYST ... | Oakley Daniel Thomas | Chief Operating Off ... | Buy | P | 1.75 | 10,000 | 17,500 | 20,951 | 11 K to 21 K (+91.32 %) |
Mar 05 2019 | BASI | BIOANALYTICAL SYST ... | Oakley Daniel Thomas | Chief Operating Off ... | Buy | P | 1.54 | 125 | 193 | 10,951 | 10.8 K to 11 K (+1.15 %) |
Mar 01 2019 | BASI | BIOANALYTICAL SYST ... | Sagartz John E | Director | Buy | L | 1.43 | 2,500 | 3,575 | 2,500 | 0 to 2.5 K |
Mar 01 2019 | BASI | BIOANALYTICAL SYST ... | Leasure Robert Jr. | President and CEO | Buy | P | 1.62 | 10,000 | 16,200 | 89,615 | 79.6 K to 89.6 K (+12.56 %) |
Mar 01 2019 | BASI | BIOANALYTICAL SYST ... | Leasure Robert Jr. | President and CEO | Buy | P | 1.51 | 8,900 | 13,439 | 79,615 | 70.7 K to 79.6 K (+12.59 %) |
Feb 28 2019 | BASI | BIOANALYTICAL SYST ... | Oakley Daniel Thomas | Chief Operating Off ... | Buy | P | 1.53 | 10,826 | 16,564 | 10,826 | 0 to 10.8 K |
Feb 12 2019 | BASI | BIOANALYTICAL SYST ... | Neff R Matthew | Director | Option Exercise | A | 1.42 | 10,000 | 14,200 | 10,000 | |
Feb 12 2019 | BASI | BIOANALYTICAL SYST ... | Davis Gregory Cole | Director | Option Exercise | A | 1.42 | 10,000 | 14,200 | 10,000 | |
Feb 12 2019 | BASI | BIOANALYTICAL SYST ... | Johnson Richard Allen | Director | Option Exercise | A | 1.42 | 10,000 | 14,200 | 10,000 | |
Feb 12 2019 | BASI | BIOANALYTICAL SYST ... | Perrow Wendy | Director | Option Exercise | A | 1.42 | 10,000 | 14,200 | 10,000 | |
Feb 12 2019 | BASI | BIOANALYTICAL SYST ... | Downing Philip A | Sr. VP, Preclinical ... | Option Exercise | A | 1.42 | 25,000 | 35,500 | 25,000 | |
Feb 12 2019 | BASI | BIOANALYTICAL SYST ... | Blumhoff Jill | VP, Finance & CFO | Option Exercise | A | 1.42 | 25,000 | 35,500 | 25,000 | |
Feb 12 2019 | BASI | BIOANALYTICAL SYST ... | Baim Michael | VP Bioanalytical Se ... | Option Exercise | A | 1.42 | 15,000 | 21,300 | 15,000 | |
Feb 12 2019 | BASI | BIOANALYTICAL SYST ... | Oakley Daniel Thomas | Chief Operating Off ... | Option Exercise | A | 1.42 | 35,000 | 49,700 | 35,000 | |
Jan 16 2019 | BASI | BIOANALYTICAL SYST ... | Leasure Robert Jr. | President and CEO | Option Exercise | A | 1.30 | 55,000 | 71,500 | 55,000 | |
Jan 16 2019 | BASI | BIOANALYTICAL SYST ... | Leasure Robert Jr. | President and CEO | Grant | A | 0.00 | 10,000 | 0 | 70,715 | 60.7 K to 70.7 K (+16.47 %) |
Jan 16 2019 | BASI | BIOANALYTICAL SYST ... | Leasure Robert Jr. | President and CEO | Grant | A | 0.00 | 34,615 | 0 | 60,715 | 26.1 K to 60.7 K (+132.62 %) |
Sep 18 2018 | BASI | BIOANALYTICAL SYST ... | KISSINGER PETER | 10% Owner | Buy | P | 1.74 | 10,000 | 17,382 | 1,033,457 | 1 M to 1 M (+0.98 %) |
Sep 18 2018 | BASI | BIOANALYTICAL SYST ... | Neff R Matthew | Director | Buy | P | 1.66 | 2,500 | 4,150 | 15,000 | 12.5 K to 15 K (+20.00 %) |
Sep 18 2018 | BASI | BIOANALYTICAL SYST ... | Neff R Matthew | Director | Buy | L | 1.65 | 2,500 | 4,125 | 12,500 | 10 K to 12.5 K (+25.00 %) |
Sep 18 2018 | BASI | BIOANALYTICAL SYST ... | Blumhoff Jill | VP, Finance & CFO | Buy | L | 1.62 | 450 | 729 | 1,311 | 861 to 1.3 K (+52.26 %) |
Sep 12 2018 | BASI | BIOANALYTICAL SYST ... | Downing Philip A | Sr. VP, Preclinical ... | Buy | P | 1.67 | 5,000 | 8,350 | 20,765 | 15.8 K to 20.8 K (+31.72 %) |
Feb 20 2018 | BASI | BIOANALYTICAL SYST ... | Downing Philip A | Sr. VP, Preclinical ... | Buy | P | 1.46 | 5,000 | 7,300 | 15,765 | 10.8 K to 15.8 K (+46.45 %) |
Oct 31 2017 | BASI | BIOANALYTICAL SYST ... | Neff R Matthew | Director | Option Exercise | A | 1.94 | 10,000 | 19,400 | 10,000 | |
Oct 31 2017 | BASI | BIOANALYTICAL SYST ... | Perrow Wendy | Director | Option Exercise | A | 1.94 | 10,000 | 19,400 | 10,000 | |
Oct 31 2017 | BASI | BIOANALYTICAL SYST ... | Davis Gregory Cole | Director | Option Exercise | A | 1.94 | 10,000 | 19,400 | 10,000 | |
Oct 31 2017 | BASI | BIOANALYTICAL SYST ... | Johnson Richard Allen | Director | Option Exercise | A | 1.94 | 10,000 | 19,400 | 10,000 | |
Oct 31 2017 | BASI | BIOANALYTICAL SYST ... | Downing Philip A | VP, Preclinical Srv ... | Option Exercise | A | 1.94 | 20,000 | 38,800 | 20,000 | |
Oct 31 2017 | BASI | BIOANALYTICAL SYST ... | Blumhoff Jill | VP, Finance & CFO | Option Exercise | A | 1.94 | 20,000 | 38,800 | 20,000 | |
Sep 08 2017 | BASI | BIOANALYTICAL SYST ... | Neff R Matthew | Director | Buy | P | 1.50 | 5,000 | 7,500 | 10,000 | 5 K to 10 K (+100.00 %) |
Aug 23 2017 | BASI | BIOANALYTICAL SYST ... | Davis Gregory Cole | Director | Buy | P | 1.70 | 5,000 | 8,500 | 5,000 | 0 to 5 K |
Aug 23 2017 | BASI | BIOANALYTICAL SYST ... | Neff R Matthew | Director | Buy | P | 1.70 | 5,000 | 8,500 | 5,000 | 0 to 5 K |
Mar 17 2017 | BASI | BIOANALYTICAL SYST ... | Blumhoff Jill | VP, Finance & CFO | Option Exercise | M | 1.40 | 500 | 700 | 0 | |
Mar 17 2017 | BASI | BIOANALYTICAL SYST ... | Blumhoff Jill | VP, Finance & CFO | Option Exercise | M | 1.01 | 200 | 202 | 0 | |
Mar 17 2017 | BASI | BIOANALYTICAL SYST ... | Blumhoff Jill | VP, Finance & CFO | Payment of Exercise | F | 1.66 | 422 | 701 | 861 | 1.3 K to 861 (-32.89 %) |
Mar 17 2017 | BASI | BIOANALYTICAL SYST ... | Blumhoff Jill | VP, Finance & CFO | Buy | M | 1.40 | 500 | 700 | 1,283 | 783 to 1.3 K (+63.86 %) |
Mar 17 2017 | BASI | BIOANALYTICAL SYST ... | Blumhoff Jill | VP, Finance & CFO | Payment of Exercise | F | 1.66 | 1,217 | 2,020 | 783 | 2 K to 783 (-60.85 %) |
Mar 17 2017 | BASI | BIOANALYTICAL SYST ... | Blumhoff Jill | VP, Finance & CFO | Buy | M | 1.01 | 2,000 | 2,020 | 2,000 | 0 to 2 K |
Mar 15 2017 | BASI | BIOANALYTICAL SYST ... | Downing Philip A | VP, Preclinical Srv ... | Option Exercise | M | 1.01 | 10,000 | 10,100 | 0 | |
Mar 15 2017 | BASI | BIOANALYTICAL SYST ... | Downing Philip A | VP, Preclinical Srv ... | Payment of Exercise | F | 1.62 | 6,235 | 10,101 | 10,765 | 17 K to 10.8 K (-36.68 %) |
Mar 15 2017 | BASI | BIOANALYTICAL SYST ... | Downing Philip A | VP, Preclinical Srv ... | Buy | M | 1.01 | 10,000 | 10,100 | 17,000 | 7 K to 17 K (+142.86 %) |
May 27 2016 | BASI | BIOANALYTICAL SYST ... | Dougherty Connie Leigh | VP, Business Develo ... | Buy | P | 0.92 | 423 | 389 | 9,074 | 8.7 K to 9.1 K (+4.89 %) |
May 25 2016 | BASI | BIOANALYTICAL SYST ... | Dougherty Connie Leigh | VP, Business Develo ... | Buy | P | 0.92 | 96 | 88 | 8,651 | 8.6 K to 8.7 K (+1.12 %) |
May 23 2016 | BASI | BIOANALYTICAL SYST ... | Dougherty Connie Leigh | VP, Business Develo ... | Buy | P | 0.92 | 1,655 | 1,523 | 8,555 | 6.9 K to 8.6 K (+23.99 %) |
May 16 2016 | BASI | BIOANALYTICAL SYST ... | Blumhoff Jill | VP, Finance & CFO | Option Exercise | A | 0.94 | 10,000 | 9,400 | 10,000 | |
Mar 02 2016 | BASI | BIOANALYTICAL SYST ... | Lemke Jacqueline M | President and CEO | Buy | P | 1.17 | 6,000 | 7,020 | 9,000 | 3 K to 9 K (+200.00 %) |
Mar 02 2016 | BASI | BIOANALYTICAL SYST ... | Lemke Jacqueline M | President and CEO | Buy | P | 1.19 | 4,000 | 4,742 | 60,685 | 56.7 K to 60.7 K (+7.06 %) |
Sep 16 2015 | BASI | BIOANALYTICAL SYST ... | Downing Philip A | VP, Preclinical Srv ... | Buy | P | 1.73 | 3,000 | 5,190 | 7,000 | 4 K to 7 K (+75.00 %) |
Aug 25 2015 | BASI | BIOANALYTICAL SYST ... | Dougherty Connie Leigh | VP, Business Develo ... | Buy | P | 1.42 | 6,900 | 9,798 | 6,900 | 0 to 6.9 K |
Jun 22 2015 | BASI | BIOANALYTICAL SYST ... | Lemke Jacqueline M | President and CEO | Option Exercise | M | 1.40 | 500 | 700 | 0 | |
Jun 22 2015 | BASI | BIOANALYTICAL SYST ... | Lemke Jacqueline M | President and CEO | Option Exercise | M | 1.38 | 125,000 | 172,500 | 0 | |
Jun 22 2015 | BASI | BIOANALYTICAL SYST ... | Lemke Jacqueline M | President and CEO | Payment of Exercise | F | 2.12 | 96,815 | 205,248 | 56,685 | 153.5 K to 56.7 K (-63.07 %) |
Jun 22 2015 | BASI | BIOANALYTICAL SYST ... | Lemke Jacqueline M | President and CEO | Buy | M | 1.40 | 500 | 700 | 153,500 | 153 K to 153.5 K (+0.33 %) |
Jun 22 2015 | BASI | BIOANALYTICAL SYST ... | Lemke Jacqueline M | President and CEO | Buy | M | 1.38 | 125,000 | 172,500 | 153,000 | 28 K to 153 K (+446.43 %) |
Mar 17 2015 | BASI | BIOANALYTICAL SYST ... | Downing Philip A | VP, Preclinical Srv ... | Option Exercise | A | 2.00 | 10,000 | 20,000 | 10,000 | |
Mar 03 2015 | BASI | BIOANALYTICAL SYST ... | Lemke Jacqueline M | President and CEO | Buy | P | 2.04 | 3,000 | 6,120 | 3,000 | 0 to 3 K |
Mar 03 2015 | BASI | BIOANALYTICAL SYST ... | Lemke Jacqueline M | President and CEO | Buy | P | 2.04 | 7,000 | 14,280 | 28,000 | 21 K to 28 K (+33.33 %) |
Sep 17 2014 | BASI | BIOANALYTICAL SYST ... | Dougherty Connie Leigh | VP, Business Develo ... | Option Exercise | A | 2.35 | 10,000 | 23,500 | 10,000 | |
Aug 26 2014 | BASI | BIOANALYTICAL SYST ... | Devine John P | VP--Toxicology | Option Exercise | M | 1.01 | 2,500 | 2,525 | 2,500 | |
Aug 26 2014 | BASI | BIOANALYTICAL SYST ... | Devine John P | VP--Toxicology | Buy | M | 1.01 | 2,500 | 2,525 | 2,500 | 0 to 2.5 K |
Jun 17 2014 | BASI | BIOANALYTICAL SYST ... | Devine John P | VP--Toxicology | Option Exercise | M | 1.01 | 5,000 | 5,050 | 5,000 | |
Jun 17 2014 | BASI | BIOANALYTICAL SYST ... | Devine John P | VP--Toxicology | Sell | S | 2.64 | 3,130 | 8,263 | 0 | 3.1 K to 0 (-100.00 %) |
Jun 17 2014 | BASI | BIOANALYTICAL SYST ... | Devine John P | VP--Toxicology | Payment of Exercise | F | 2.70 | 1,870 | 5,049 | 3,130 | 5 K to 3.1 K (-37.40 %) |
Jun 17 2014 | BASI | BIOANALYTICAL SYST ... | Devine John P | VP--Toxicology | Buy | M | 1.01 | 5,000 | 5,050 | 5,000 | 0 to 5 K |
Jun 10 2014 | BASI | BIOANALYTICAL SYST ... | Potrzebowski Jeffrey | VP, Finance & CFO | Option Exercise | A | 2.66 | 10,000 | 26,600 | 10,000 | |
Jun 04 2014 | BASI | BIOANALYTICAL SYST ... | Bourdage James Sevall | VP, Bioanalytical S ... | Option Exercise | A | 2.71 | 10,000 | 27,100 | 10,000 | |
Jan 17 2013 | BASI | BIOANALYTICAL SYST ... | Lemke Jacqueline M | Intrm Pres & CEO, C ... | Option Exercise | A | 1.40 | 500 | 700 | 500 | |
Jan 17 2013 | BASI | BIOANALYTICAL SYST ... | Devine John P | VP--Toxicology | Option Exercise | A | 1.40 | 500 | 700 | 500 | |
Jan 17 2013 | BASI | BIOANALYTICAL SYST ... | Payne Lori | VP-Bioanalytical Se ... | Option Exercise | A | 1.40 | 500 | 700 | 500 | |
Oct 16 2012 | BASI | BIOANALYTICAL SYST ... | Lemke Jacqueline M | Intrm Pres & CEO, C ... | Option Exercise | A | 1.32 | 50,000 | 66,000 | 50,000 | |
Aug 20 2012 | BASI | BIOANALYTICAL SYST ... | Johnson Richard Allen | Director | Buy | P | 1.26 | 10,000 | 12,600 | 10,000 | 0 to 10 K |
Aug 20 2012 | BASI | BIOANALYTICAL SYST ... | Sullivan A. Charlene | Director | Buy | P | 1.26 | 10,000 | 12,600 | 10,000 | 0 to 10 K |
Aug 20 2012 | BASI | BIOANALYTICAL SYST ... | Lemke Jacqueline M | Intrm Pres & CEO, C ... | Buy | P | 1.26 | 20,000 | 25,200 | 21,000 | 1,000 to 21 K (+2,000.00 %) |
Aug 20 2012 | BASI | BIOANALYTICAL SYST ... | CRABB DAVID W | Director | Buy | P | 1.26 | 10,000 | 12,600 | 11,300 | 1.3 K to 11.3 K (+769.23 %) |
Aug 20 2012 | BASI | BIOANALYTICAL SYST ... | Landis John B. | Director | Buy | P | 1.26 | 30,000 | 37,800 | 30,000 | 0 to 30 K |
Aug 20 2012 | BASI | BIOANALYTICAL SYST ... | Boulet Larry Steven | Director | Buy | P | 1.26 | 11,500 | 14,490 | 15,000 | 3.5 K to 15 K (+328.57 %) |
Aug 20 2012 | BASI | BIOANALYTICAL SYST ... | OMACHINSKI DAVID L | Director | Buy | P | 1.26 | 10,000 | 12,600 | 20,000 | 10 K to 20 K (+100.00 %) |
Jul 09 2012 | BASI | BIOANALYTICAL SYST ... | Johnson Richard Allen | Director | Option Exercise | A | 0.86 | 15,000 | 12,900 | 15,000 | |
Jul 09 2012 | BASI | BIOANALYTICAL SYST ... | Landis John B. | Director | Option Exercise | A | 0.86 | 15,000 | 12,900 | 15,000 | |
Apr 11 2012 | BASI | BIOANALYTICAL SYST ... | Chilton Anthony S | CEO and President | Option Exercise | A | 1.38 | 25,000 | 34,500 | 25,000 | |
Apr 11 2012 | BASI | BIOANALYTICAL SYST ... | Payne Lori | VP Bioanalytical Se ... | Option Exercise | A | 1.38 | 20,000 | 27,600 | 20,000 | |
Apr 11 2012 | BASI | BIOANALYTICAL SYST ... | Lemke Jacqueline M | CFO & Vice Presiden ... | Option Exercise | A | 1.38 | 125,000 | 172,500 | 125,000 | |
Feb 28 2011 | BASI | BIOANALYTICAL SYST ... | Chilton Anthony S | CEO and President | Option Exercise | A | 2.25 | 25,000 | 56,250 | 25,000 | |
Sep 16 2010 | BASI | BIOANALYTICAL SYST ... | OMACHINSKI DAVID L | Director | Buy | P | 0.90 | 10,000 | 9,000 | 10,000 | 0 to 10 K |
Aug 19 2010 | BASI | BIOANALYTICAL SYST ... | Hidalgo Alberto F Jr | VP, Bus. Developmen ... | Option Exercise | A | 1.00 | 30,000 | 30,000 | 30,000 | |
Aug 18 2010 | BASI | BIOANALYTICAL SYST ... | DANIELS LESLIE B | Director | Option Exercise | A | 1.01 | 5,000 | 5,050 | 15,000 |